Skip to main content
. 2018 Mar 22;97(Suppl 1):S48–S113. doi: 10.1055/s-0043-121596

Fig. 4.

Fig. 4

Immunohistochemical proof of the expression of β2 microglobulin (β2M) as marker of functional membrane-based HLA I expression (top left). The loss of the expression of β2M on tumor cells (bottom left) correlates with a better overall survival of patients with OSCC (right).